Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 23541-50-6 | Product Number: D4532
Daunorubicin Hydrochloride
Purity: >98.0%(N)
- Hydroxydaunorubicin Hydrochloride
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
20MG |
$246.00
|
2 | 1 | 19 |
|
100MG |
$612.00
|
1 | 1 | ≥100 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | D4532 |
Purity / Analysis Method | >98.0%(N) |
Molecular Formula / Molecular Weight | C__2__7H__2__9NO__1__0·HCl = 563.98 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
Packaging and Container | 20MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 23541-50-6 |
Related CAS RN | 20830-81-3 |
Reaxys Registry Number | 4229221 |
PubChem Substance ID | 253661912 |
Merck Index (14) | 2832 |
MDL Number | MFCD04974507 |
Appearance | Orange to Red powder to crystal |
Purity(HPLC) | min. 96.0 area% |
Purity(with Total Nitrogen) | min. 98.0 %(calcd.on dried substance) |
Specific rotation [a]20/D | +250 to +275 deg(C=0.15, MeOH) |
Drying loss | max. 7.5 % |
Melting Point | 167 °C(dec.) |
Specific Rotation | 260° (C=0.15,MeOH) |
Maximum Absorption Wavelength | 477(H2O) nm |
Solubility in water | Soluble |
Solubility (soluble in) | Methanol |
Solubility (insoluble in) | Ether, Chloroform, Benzene |
Pictogram | |
Signal Word | Danger |
Hazard Statements | H301 : Toxic if swallowed. H317 : May cause an allergic skin reaction. H334 : May cause allergy or asthma symptoms or breathing difficulties if inhaled. H341 : Suspected of causing genetic defects. H351 : Suspected of causing cancer. H413 : May cause long lasting harmful effects to aquatic life. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P285 : In case of inadequate ventilation wear respiratory protection. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P272 : Contaminated work clothing must not be allowed out of the workplace. P342 + P311 : If experiencing respiratory symptoms: Call a POISON CENTER/doctor. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P302 + P352 : IF ON SKIN: Wash with plenty of soap and water. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. P363 : Wash contaminated clothing before reuse. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P304 + P341: IF INHALED: If breathing is difficult, remove person to fresh air and keep comfortable for breathing. P405 : Store locked up. |
RTECS# | HB7878000 |
UN Number (DOT-AIR) | UN2811 |
Class (DOT-AIR) | 6.1 |
Packing Group (TCI-A) | III |
HS Number | 2942.00.0500 |
References
- 1) Identification and validation of small molecules that enhance recombinant adeno-associated virus transduction following high-throughput screens
References
- Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals
- Biosynthetic studies of daunorubicin and tetracenomycin C (a review)
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin (a review)
- Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity (a review)
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.